Glaukos Raises $29.5M

Laguna Hills-based Glaukos, which is developing a medical device for the treatment of glaucoma, has raised $29.5M in a Series E round, the firm confirmed Thursday. According to Richard Harrison, the firm's CFO, the funding was led by Meritech Capital Partners, which contributed $16M of the round, and also included all prior investors, including Domain Associates, Frazier Healthcare Ventures, Interwest Partners, Montreux Equity Partners, Orbimed Advisors, and Versant Ventures. The Glaukos management team has previously been involved with such firm as Allergan, Advanced Medical Optics, Bausch & Lomb, Edwards Lifesciences, and Chiron. More information »